The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice.
Qianying Gao,Wencong Wang,Yuqing Lan,Xiaoqing Chen,Wei Yang,Yongguang Yuan,Juan Tan,Yao Zong,Zhaoxin Jiang
DOI: https://doi.org/10.2147/IJN.S37635
IF: 7.033
2013-01-01
International Journal of Nanomedicine
Abstract:Aim: To evaluate the effects of small interference RNA protein kinase C-alpha (siRNA-PKC alpha) on experimental proliferative vitreoretinopathy (PVR) induced by dispase in mice. Methods: C57BL/6 mice PVR models (4-6 weeks old) were induced by intravitreal injection of dispase and then equally divided into six groups. After 1 week, the five treatment groups received 2 mu L intravitreal injections of siRNA-PKC alpha at a concentration of 250 nM, 500 nM, 750 nM, 1000 nM, and 1500 nM, respectively, while the negative control group received 2 mu L of 500 nM no-silencing siRNA. SiRNA-PKC alpha was transfected by a square wave electroporator. Postoperative ophthalmic observations of lens clarity and the fundus of the eyes were performed periodically. The eyeballs of the mice were enucleated and imbedded in optimal cutting temperature to perform histological and immunofluorescence analysis at the end of a 4-week observation period. Results: Four weeks after the siRNA-PKC alpha injections, there are 100% lens dissolution and 100% PVR in the 250 nM group and 70%, 70%, 70%, and 50% PVR in the 500 nM, 750 nM, 1000 nM, and 1500 nM groups, respectively, which is significantly different from the negative group. Abnormalities in fundus appearance were related to the concentrations of siRNA-PKC alpha; a higher concentration of siRNA-PKC alpha resulted in a more normal fundus. Histological sections by hematoxylin-eosin staining of the eyes support the clinical observation. Immunofluorescence analysis showed that RPE65, glutamine synthase, glial acidic fibrillary protein, and alpha-smooth muscle actin were increasing in the retina with the decreasing concentration of siRNA-PKC alpha, indicating that intraocular siRNA-PKC alpha can partly inhibit changes of markers for glia cells, fibroblast cells, retinal pigment epithelium cells, and Muller cells in the process of PVR. Conclusion: Gene therapy with siRNA-PKC alpha could effectively inhibit PVR in mice and provide us with a novel therapeutic target on PVR.